» Articles » PMID: 29485036

The Evolving Clinical Picture of Chronic Prostatitis/chronic Pelvic Pain Syndrome (CP/CPPS): A Look at 1310 Patients over 16 Years

Overview
Specialty Urology
Date 2018 Feb 28
PMID 29485036
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Two decades of increasing understanding of etiopathogenesis and clinical phenotyping produces an impression the clinical face of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is changing. We sought to retrospectively analyze trends in CP/CPPS patients presenting to our clinic for evaluation over a 16-year period.

Methods: Patients with CP/CPPS presenting to a tertiary clinic were evaluated prospectively from 1998-2014 with Chronic Prostatitis Symptom Index (CPSI) and UPOINT (urinary, psychosocial, organ-specific, infection, neurogenic, and tenderness) categorization. Patients were stratified in four cohorts, based on year of presentation, and we retrospectively analyzed variations in symptom scores and patterns, UPOINT categorization, and treatment modalities amongst cohorts.

Results: Mean age of the 1310 CP/CPPS patients was 44.7 years, while mean CPSI pain, urination, and total scores were 10.6, 4.8, and 23.3, respectively. The most prevalent UPOINT domain, urinary (U) (71.8%) was associated with a higher CPSI urination score (6.3), more frequent penile tip pain (37%), dysuria (48%), and more treatment with alpha-blockers (70%). Increase in UPOINT domains was associated with higher CPSI pain, quality of life (QoL), and total scores. Trends over time included increased prevalence of psychosocial (P), organ (O), and tenderness (T) domains, as well as increased use of alpha-blockers, neuromodulation, and phytotherapy as treatment modalities. There was little variation in age, CPSI scores, and pain locations over time.

Conclusions: The changing clinical face of CP/CPPS reflects the increased recognition of psychosocial (P domain) and pelvic floor pain (T domain), along with the concomitant use of associated therapies. There was little variation of pain/urinary symptom patterns and QoL.

Citing Articles

Are fascial strains involved in chronic pelvic pain syndrome? An exploratory matched case-control study.

Origo D, Dal Farra F, Bruni M, Catalano A, Marzagalli L, Bruini I Int Urol Nephrol. 2022; 55(3):511-518.

PMID: 36522568 DOI: 10.1007/s11255-022-03448-2.


The Translational Role of Animal Models for Estrogen-Related Functional Bladder Outlet Obstruction and Prostatic Inflammation.

Santti R, Yatkin E, Bernoulli J, Streng T Vet Sci. 2022; 9(2).

PMID: 35202312 PMC: 8877003. DOI: 10.3390/vetsci9020060.


Physiotherapy and combined cognitive-behavioural therapy for patients with chronic pelvic pain syndrome: results of a non-randomised controlled feasibility trial.

Brunahl C, Klotz S, Dybowski C, Albrecht R, Hoink J, Fisch M BMJ Open. 2021; 11(12):e053421.

PMID: 34907064 PMC: 8671982. DOI: 10.1136/bmjopen-2021-053421.


Efficacy and Safety of Drug Combinations for Chronic Pelvic Pain: Protocol for a Systematic Review.

Mohiuddin M, Park R, Wesselmann U, Pukall C, Jarvi K, Nickel C JMIR Res Protoc. 2021; 10(5):e21909.

PMID: 33999006 PMC: 8167620. DOI: 10.2196/21909.


Search for Novel Diagnostic Biomarkers of Prostate Inflammation-Related Disorders: Role of Transglutaminase Isoforms as Potential Candidates.

Savoca M, Inferrera A, Verderio E, Caccamo D Mediators Inflamm. 2019; 2019:7894017.

PMID: 31360119 PMC: 6652054. DOI: 10.1155/2019/7894017.


References
1.
Wagenlehner F, van Till J, Magri V, Perletti G, Houbiers J, Weidner W . National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. Eur Urol. 2012; 63(5):953-9. DOI: 10.1016/j.eururo.2012.10.042. View

2.
Rees J, Abrahams M, Doble A, Cooper A . Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline. BJU Int. 2015; 116(4):509-25. PMC: 5008168. DOI: 10.1111/bju.13101. View

3.
Litwin M, McNaughton-Collins M, Fowler Jr F, Nickel J, Calhoun E, Pontari M . The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. 1999; 162(2):369-75. DOI: 10.1016/s0022-5347(05)68562-x. View

4.
Nickel J, Pontari M, Moon T, Gittelman M, Malek G, Farrington J . A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol. 2003; 169(4):1401-5. DOI: 10.1097/01.ju.0000054983.45096.16. View

5.
Anothaisintawee T, Attia J, Nickel J, Thammakraisorn S, Numthavaj P, McEvoy M . Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA. 2011; 305(1):78-86. DOI: 10.1001/jama.2010.1913. View